RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Squamous Cell Carcinoma - Pipeline Review, Q4 2010
Dec 2010 - 27 pages - $500
Squamous Cell Carcinoma Global Clinical Trials Review, Q4, 2010
Dec 2010 - 73 pages - $1,000
Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy
Feb 2011 - 6 pages - $500
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
Epidemiology: Non-Small Cell Lung Cancer – Despite global efforts to stop smoking, incidence rates will remain unchanged
Nov 2011 - 48 pages - $5,700
Renal Cell Carcinoma - Pipeline Review, Q3 2011
Jul 2011 - 390 pages - $500
Squamous Cell Carcinoma - Pipeline Review, H2 2011
Aug 2011 - 236 pages - $500
Epidemiology: Renal Cell Cancer – Incident cases set to soar
Mar 2011 - 29 pages - $3,800
Renal Cell Carcimona Drug Discoveries - what the future holds
Feb 2010 - 138 pages - $2,265
Renal Cell Carcinoma Global Clinical Trials Review, Q4, 2010
Dec 2010 - 75 pages - $1,000
More Related Market Research Reports >>>

Your selection

Industry sector
Academic/Research del
Diagnostic del
Therapeutic target
Oncology del
Skin cancer del
Squamous cell carcinoma del
Year
2001 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us